IFM Therapeutics develops medicines that target the innate immune system to address inflammation-driven diseases and cancer. They are focused on advancing small molecule therapies.
investor of
Metrics
marketPRIVATE
msh_idCOM:IFMTHERA
localeus
websitehttps://www.ifmthera.com/
source_ref0c79aa7b-e003-4744-a4aa-ea6e0d9c16ef
products_or_servicesDevelopment of first-in-class small molecule drugs targeting innate immune responses.
United States